A Blood Test for Alzheimer's

January 2011
Time International (Atlantic Edition);1/24/2011, Vol. 177 Issue 3, p8
The article reports on the discovery of blood molecules that bind to antibodies made by people suffering from the neurogenerative disease Alzheimer's, which can be used to diagnose the disease through a blood test.


Related Articles

  • New diagnostic test for Alzheimer's looks at cerebrospinal fluid.  // Modern Medicine;Sep96, Vol. 64 Issue 9, p14 

    Reports on the research finding about the effectiveness of AD7C, the test designed to diagnose or rule out the presence of Alzheimer's disease. Description of the procedure in the conduct of the test; Use of the test on different kinds of patients.

  • Keeping current on Alzheimer's disease. Kelley, Roger E.; D'Epiro, Peter // Patient Care;6/15/1999, Vol. 33 Issue 11, p127 

    Focuses on drugs that may aid in the timely identification of patients at risk for Alzheimer's disease (AD). Available therapies that may delay disease onset and progression; Diagnostic assessment; Cholinomimetic therapy; Antidepressant therapy; Use of nonsteroidal anti-inflammatory drugs;...

  • Is it Alzheimer's? Rodgers, Katie // Drug Topics;11/7/94, Vol. 138 Issue 21, p22 

    Looks at the warning signs of Alzheimer's disease. Memory loss; Difficulty performing familiar tasks; Problems with language; Mood swings; Loss of initiative.

  • Advance warning of Alzheimer's? Bruck, Laura // Nursing Homes: Long Term Care Management;Jul/Aug95, Vol. 44 Issue 6, p57 

    Reports on the result of a study conducted which suggests that diagnostic technology like genetic typing combined with Positron Emission Tomography may provide a method of predicting the development of Alzheimer's disease up to 20 years before the onset of symptoms. Hope of findings to lead to...

  • Reduced brain function can predict Alzheimer's.  // Psychotherapy Letter;Apr95, Vol. 7 Issue 4, p7 

    Cites research at UCLA Medical School on the development of reduced brain function in people who inherit the gene apolipoprotein-E4 before they experience clinical symptoms of Alzheimer's disease. Identification of Alzheimer's patients in the early stages via a combination of genetic testing...

  • Aphasia, apraxia predicts rapid decline in Alzheimer's patients.  // Geriatrics;Oct93, Vol. 48 Issue 10, p83 

    Summarizes `Development of Aphasia, Apraxia, and Agnosia and Decline in Alzheimer's Disease' by J.A. Yesavage, J.O. Brooks, J. Taylor, et al., published in American Journal of Psychiatry, 1993, Volume 150: 742-7. Declining mental function of patients with Alzheimer's disease (AD); Distinct...

  • Tau in cerebrospinal fluid: A diagnostic marker for AD?  // Geriatrics;Dec94, Vol. 49 Issue 12, p55 

    Reports on the discovery of an assay for the diagnosis of Alzheimer's disease and for the differentiation of the disease from other dementia-causing disorders. Facilitation of diagnosis through the cerebrospinal fluid level of tau, a chemical associated with the disease; Possibility of the...

  • Is test to diagnose Alzheimer's disease just an eyedrop away?  // Geriatrics;Jan95, Vol. 50 Issue 1, p19 

    Reports on an eye examination technique for diagnosing Alzheimer's disease developed by researchers at Brigham & Women's Hospital in Boston, Massachusetts. Use of the drug tropicamide in diagnosis; Accuracy; Correlation of tropicamide sensitivity among Down's syndrome and Alzheimer's disease...

  • SPECT imaging holds potential for diagnosing AD.  // Geriatrics;Aug98, Vol. 53 Issue 8, p12 

    Reports that a single phonton emission computed tomography (SPECT) can be used to identify persons at risk for developing Alzheimer's disease (AD), according to a study conducted by a group of researchers from Massachusetts. Perception that SPECT could give clinicians an edge in preventing...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics